ANI Pharma (ANIP)
71.08
+0.89 (1.27%)
Upcoming Events
Latest Headlines
Form 144 ANI PHARMACEUTICALS INC Filed by: Thoma Jeanne
September 11, 2026 4:33 PM - SEC Filing
Leerink Starts ANI Pharmaceuticals (ANIP) at Outperform
September 9, 2026 6:49 AM - StreetInsider
ANI Pharmaceuticals to Present at September Investor Conferences
September 3, 2026 6:55 AM - StreetInsider
Form 4 ANI PHARMACEUTICALS INC For: Aug 19 Filed by: Gosebruch Henry O
August 27, 2026 4:22 PM - SEC Filing
Form 3 ANI PHARMACEUTICALS INC For: Aug 19 Filed by: Gosebruch Henry O
August 27, 2026 4:21 PM - SEC Filing
Form 4 ANI PHARMACEUTICALS INC For: Aug 25 Filed by: Lalwani Nikhil
August 26, 2026 6:15 PM - SEC Filing
Form 144 ANI PHARMACEUTICALS INC Filed by: Lalwani Nikhil
August 25, 2026 4:42 PM - SEC Filing
Form 8-K ANI PHARMACEUTICALS INC For: Aug 19
August 24, 2026 7:01 AM - SEC Filing
ANI Pharmaceuticals adds Henry Gosebruch to its board
August 24, 2026 6:55 AM - StreetInsider
ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors
August 24, 2026 6:55 AM - StreetInsider
Form 4 ANI PHARMACEUTICALS INC For: Aug 13 Filed by: Cook Meredith
August 13, 2026 4:34 PM - SEC Filing
Form 4 ANI PHARMACEUTICALS INC For: Aug 10 Filed by: Gutwerg Ori
August 11, 2026 8:58 PM - SEC Filing
ANI Pharmaceuticals (ANIP) PT Lowered to $119 at Guggenheim
August 10, 2026 7:28 AM - StreetInsider
ANI Pharmaceuticals (ANIP) PT Lowered to $90 at Canaccord
August 10, 2026 7:00 AM - StreetInsider
ANI Pharma (ANIP) Tops Q2 EPS by 18c ; Offers Guidance
August 7, 2026 7:34 AM - StreetInsider
Form 10-Q ANI PHARMACEUTICALS INC For: Jun 30
August 7, 2026 7:02 AM - SEC Filing
Form 8-K ANI PHARMACEUTICALS INC For: Aug 07
August 7, 2026 7:00 AM - SEC Filing
ANI Pharmaceuticals Reports Record Second Quarter 2026 Financial Results
August 7, 2026 6:50 AM - StreetInsider
Form 4 ANI PHARMACEUTICALS INC For: Jul 29 Filed by: CAREY STEPHEN P.
July 30, 2026 4:03 PM - SEC Filing
Form 144 ANI PHARMACEUTICALS INC Filed by: CAREY STEPHEN P.
July 29, 2026 4:22 PM - SEC Filing
Form SCHEDULE 13G/A ANI PHARMACEUTICALS INC Filed by: BlackRock, Inc.
July 27, 2026 4:26 PM - SEC Filing
ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET
July 24, 2026 6:50 AM - StreetInsider
Form 4 ANI PHARMACEUTICALS INC For: Jul 18 Filed by: Cook Meredith
July 21, 2026 4:32 PM - SEC Filing
Form S-8 ANI PHARMACEUTICALS INC
July 17, 2026 4:23 PM - SEC Filing
ANI Pharmaceuticals to appeal Delaware court rulings in CG Oncology case
July 16, 2026 4:36 PM - StreetInsider
ANI Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter
July 16, 2026 4:34 PM - Globe NewsWire
Canaccord Starts ANI Pharmaceuticals (ANIP) at Hold
July 16, 2026 4:05 PM - StreetInsider
Form 4 ANI PHARMACEUTICALS INC For: Jul 13 Filed by: Cook Meredith
July 14, 2026 4:02 PM - SEC Filing
ANI Pharmaceuticals eye implant trial meets both primary endpoints
July 13, 2026 6:50 AM - StreetInsider
ANI Pharmaceuticals Announces Positive Six-Month Topline Data from the Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial Evaluating Fluocinolone Acetonide Intravitreal Implant in Patients with Chroni
July 13, 2026 6:50 AM - StreetInsider
Form 144 ANI PHARMACEUTICALS INC Filed by: Walsh Patrick D
July 7, 2026 4:04 PM - SEC Filing
Form 4 ANI PHARMACEUTICALS INC For: Jul 02 Filed by: CAREY STEPHEN P.
July 6, 2026 9:40 PM - SEC Filing
Form 4 ANI PHARMACEUTICALS INC For: Jun 29 Filed by: CAREY STEPHEN P.
June 30, 2026 4:15 PM - SEC Filing
Full Article List
